Merck

Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study
Fierce Pharma
Fri, 07/12/24 - 11:28 am
Novo Nordisk
Ozempic
dementia
Merck
Januvia
Merck puts 1,000-plus Zostavax lawsuits to bed after plaintiffs file for dismissal
Fierce Pharma
Tue, 07/9/24 - 11:23 am
Merck
Zostavax
vaccines
shingles
legal
Merck opts in on Orion's hormone-dependent cancer candidates
Fierce Biotech
Mon, 07/1/24 - 09:51 pm
Merck
Orion
biobucks
cancer
Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing
Fierce Pharma
Sun, 06/30/24 - 09:59 pm
Merck
Pfizer
vaccines
pneumococcal disease
Prevnar
Capvaxive
This Recent FDA Approval Is Bad News for Pfizer
Motley Fool
Thu, 06/27/24 - 11:31 am
Pfizer
Merck
FDA
vaccines
pneumococcal disease
FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters
Thu, 06/27/24 - 11:18 am
Merck
Daiichi Sankyo
cancer
FDA
patritumab deruxtecan
antibody-drug conjugate
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval
Fierce Pharma
Tue, 06/18/24 - 11:40 am
Merck
Keytruda
endometrial cancer
GSK
FDA
Merck gets shot in the arm with FDA approval for first pneumococcal vaccine designed for adults
Fierce Pharma
Mon, 06/17/24 - 10:37 pm
Merck
vaccines
FDA
pneumococcal disease
Capvaxive
V116
Merck looks for next-generation opportunities in cardiometabolic drugs
Reuters
Tue, 06/11/24 - 11:23 am
Merck
cardiometabolic diseases
weight loss
ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer
Fierce Pharma
Tue, 06/4/24 - 11:52 am
ASCO 2024
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Merck
Eisai
Bayer
Lenvima
Nexavar
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters
Mon, 06/3/24 - 11:58 am
Moderna Therapeutics
Merck
skin cancer
melanoma
vaccines
Keytruda
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences
Fierce Pharma
Mon, 06/3/24 - 11:54 am
Merck
Eli Lilly
Gilead Sciences
innovation
Inflation Reduction Act
Keytruda
PhRMA
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
BioSpace
Fri, 05/31/24 - 10:59 am
M&A
Merck
EyeBio
JNJ
Numab Therapeutics
Asahi Kasei
Calliditas Therapeutics
Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology
BioSpace
Wed, 05/29/24 - 11:54 am
Merck
EyeBio
ophthalmology
M&A
How Merck for Mothers reached 30M women through maternal health programs
Medical Marketing and Media
Mon, 05/20/24 - 05:48 pm
Merck
maternal health
Women's Health
pharma marketing
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters
Mon, 05/13/24 - 11:14 am
Merck
skin cancer
clinical trials
melanoma
vibostolimab
anti-TIGIT
The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel
Pharma Voice
Fri, 05/10/24 - 11:12 am
Daiichi Sankyo
Enhertu
oncology
Merck
Keytruda strikes out again in endometrial cancer with phase III flop
BioSpace
Thu, 05/9/24 - 11:49 am
Merck
Keytruda
clinical trials
endometrial cancer
How mRNA vaccines could be personalized cancer cures
Axios
Tue, 05/7/24 - 10:59 am
MRNA
vaccines
cancer
personalized medicine
oncology
IO Biotech
Merck
BioNTech

Pages